Oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation – Clinical and safety results - Colla, M; Offenhammer, B; Scheerer, H (J Psychiatr Res, 2024)
et al.